Health Care & Hospital Law,
Civil Litigation
Jun. 4, 2021
Allergan says there’s no false advertising if public never sees it
After a month and a half of plaintiffs’ evidence in an Orange County bench trial, one of four drug company-defendants accused of fueling the opioid crisis in California by deceptively marketing opioids as rarely addicting, moved for a defense judgment in a written brief.
It's not false advertising if the plaintiff can't prove a marketing message was ever disseminated to the public, an opioid manufacturer argued in its motion for summary judgment Thursday in a $50 billion trial.
After a month and a half of plaintiffs' evidence in an Orange County bench trial, one of four drug company-defendants accused of fueling the opioid crisis in California by deceptively marketing opioids as rarely addicting, m...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law
4 pharma companies say state has not made its case in Orange County trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid MDL against McKinsey heads to San Francisco
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Judge gets several 1,000-page motions from opioid trial plaintiffs
By Blaise Scemama
Civil Litigation
State drops 2 opioid defendants, judge mulls total dismissal
By Blaise Scemama
Civil Litigation
Dismissal motion denied, trial against opioid makers continues
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Judge denies many untimely filed plaintiffs’ documents in opioid trial
By Blaise Scemama
Criminal, 9th U.S. Circuit Court of Appeals
Defenders seek review of panel’s reinstatement of doctor’s opioid trial
By Gina Kim
Constitutional Law, Civil Litigation
Opioid trials remind us of importance of Brady rights
By Nina Marino
Health Care & Hospital Law, Civil Litigation
Plaintiffs close false advertising case against drugmakers
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
State witness says drugmakers paid for positive opioid studies
By Blaise Scemama
